Epileptogenic potential of carbapenem agents: mechanism of action, seizure rates, and clinical considerations.
about
Adverse events associated with meropenem versus imipenem/cilastatin therapy in a large retrospective cohort of hospitalized infantsSafety of high-dose doripenem in adult patients with cystic fibrosisStatus Epilepticus and Delirium Associated with Ertapenem in a Very Elderly Patient with Chronic Kidney Disease and Silent Ischaemic Cerebrovascular Disease.Clinical pharmacology of carbapenems in neonates.Optimum management of Citrobacter koseri infection.Pediatric head and neck complications of Streptococcus pneumoniae before and after PCV7 vaccination.Neurological Adverse Effects Attributable to β-Lactam Antibiotics: A Literature Review.Neurologic Complications of Commonly Used Drugs in the Hospital Setting.Ertapenem-associated neurotoxicity in the Spinal Cord Injury (SCI) population: a case series.Risk factors associated with the development of seizures among adult patients treated with ertapenem: A matched case-control studyThe risk of seizures among the carbapenems: a meta-analysis.Ertapenem-Induced Encephalopathy in a Patient With Normal Renal FunctionLevofloxacin-induced seizures in a patient without predisposing risk factors: the impact of pharmacogenetics.Antiepileptic drugs in critically ill patients.
P2860
Q24601509-7D67918F-4ABE-4A67-850F-D70F5BAEE523Q36967193-CDC026DA-785A-4FC6-91DE-4907645AFE29Q37219121-D6B39889-2D19-4A70-875E-F107F27DF4D1Q38148807-5B63E622-23B7-4080-B5C9-409D735CEDD9Q38236545-755B539D-C511-421B-A339-6ACE8430D327Q38266840-CE04F465-E248-4CD4-859E-83262A7A46C5Q38654209-3221B5CF-0874-43FE-BF3B-EF10E18FB234Q38746169-F92AE32E-FC7E-42BF-B044-5D91C5F23071Q40066215-B1C6514A-FF95-4CFB-8D57-E1FA877E1902Q41185854-5E6DE279-7482-4BAA-B4A2-DE05688F62ACQ42218823-1E1C98C8-B162-4D57-8B52-782EBC0BC438Q42323100-C55B7972-D723-4A10-A047-F6ED21851281Q44213464-B69FFB9C-D8BE-4E32-B905-F07BA4800784Q55190397-AEA22323-0AD6-45E1-9DAA-F6E016ECB5F2
P2860
Epileptogenic potential of carbapenem agents: mechanism of action, seizure rates, and clinical considerations.
description
2011 nî lūn-bûn
@nan
2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Epileptogenic potential of car ...... , and clinical considerations.
@ast
Epileptogenic potential of car ...... , and clinical considerations.
@en
Epileptogenic potential of car ...... , and clinical considerations.
@nl
type
label
Epileptogenic potential of car ...... , and clinical considerations.
@ast
Epileptogenic potential of car ...... , and clinical considerations.
@en
Epileptogenic potential of car ...... , and clinical considerations.
@nl
prefLabel
Epileptogenic potential of car ...... , and clinical considerations.
@ast
Epileptogenic potential of car ...... , and clinical considerations.
@en
Epileptogenic potential of car ...... , and clinical considerations.
@nl
P2093
P2860
P356
P1433
P1476
Epileptogenic potential of car ...... , and clinical considerations.
@en
P2093
Amanda M Ball
April D Miller
Charles L Bennett
Emily K Dornblaser
P Brandon Bookstaver
P2860
P304
P356
10.1592/PHCO.31.4.408
P407
P577
2011-04-01T00:00:00Z